Profile
ACRV VRTX REGN VRNA ARGX ALNY
Company Name Acrivon Therapeutics, Inc. Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $49.23M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.08K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Peter Blume-Jensen Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ACRV VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ACRV VRTX REGN VRNA ARGX ALNY
Last Close $2.38 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $7.58 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.05 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -68.6 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 126.67 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ACRV VRTX REGN VRNA ARGX ALNY
1 Month Return 31.49 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 71.22 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 106.96 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -54.75 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -60.47 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -62.7 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRV VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -28.89 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ACRV VRTX REGN VRNA ARGX ALNY
Asset Growth 42.18 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -87.69 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -33.4 % 9.09 % -131.37 % 24.59 %
Net Income Growth -33.4 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -67.18 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -411.79 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -411.79 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -32.66 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -54 % - -143.33 % -107.98 %
Operating 3 Year CFG -58.33 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -689.77 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -689.77 % -100 % 40.15 % 97.08 %
EPS Growth 23.36 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 23.36 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -15.91 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 350.3 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 808.37 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 808.37 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -21.51 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -55.79 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ACRV VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -56.26 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -53.71 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -68.21 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 91.9 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -2201 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 1.22 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.71 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.77 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 335.2 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.46 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -2201 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.72 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.91 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.91 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
ACRV VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.08B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.08B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -2.1 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ACRV VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.02B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.18B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.14B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.2B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ACRV VRTX REGN VRNA ARGX ALNY
Net Income $-0.08B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.59
AARD Aardvark Therapeutics, Inc. Common Stock 12.185
ABCL AbCellera Biologics Inc. 2.9955
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.0101
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.38
ABPWW 0.0132
ABSI Absci Corporation 2.435
ABUS Arbutus Biopharma Corporation 3.945
ABVC ABVC BioPharma, Inc. 1.6483
ABVX Abivax SA American Depositary Shares 125.15
ACAD ACADIA Pharmaceuticals Inc. 21.835
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.6889
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.105
ACIU AC Immune SA 2.925
ETFs With Exposure to ACRV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00008 259.93
VTI Vanguard Total Stock Market Index Fund 0.00005 337.54
IBB iShares Biotechnology ETF 0.0048 171.396
SCHB Schwab U.S. Broad Market ETF 0.0000736968 26.395
SCHA Schwab U.S. Small-Cap ETF 0.000544871 30.305
IWN iShares Russell 2000 Value ETF 0.00017 196.88
IWO iShares Russell 2000 Growth ETF 0.00305 332.135
BIB ProShares Ultra Nasdaq Biotechnology 0.0045116 84
VXF Vanguard Extended Market Index Fund 0.00044 213.85
HDG ProShares Hedge Replication ETF 0.0000771473 52.844
UWM ProShares Ultra Russell2000 0.000435315 51.87
VTHR Vanguard Russell 3000 Index Fund 0 302.39
IWC iShares Micro-Cap ETF 0.01 165.055
URTY ProShares UltraPro Russell2000 0.000348092 61.07
VTWV Vanguard Russell 2000 Value Index Fund 0.00111 173.53
VTWO Vanguard Russell 2000 Index Fund 0.00049 105.06
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 49.13
VUN.TO Vanguard U.S. Total Market Index ETF 0.00005 124.93
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00005 117.16
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00002 115
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.98
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00008 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00008 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0.00008 52.53
RYLD Global X Russell 2000 Covered Call ETF 0 15.535
VGRO.TO Vanguard Growth ETF Portfolio 0.00002 44.05
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.29
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.68
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.05
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.33
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.96
IBBQ Invesco Nasdaq Biotechnology ETF 0.005514 29.2941
DFAT Dimensional U.S. Targeted Value ETF 0.0000199 65.575
DFAS Dimensional U.S. Small Cap ETF 0.00001232 74.79
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000578 40.785
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 7.17
VTSAX Vanguard Total Stock Market Index Fund 0.00005 166.24
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 8.4975
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0059 51.26
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00044 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00005 166.27
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01 8.451
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0059 60.83
DFSU Dimensional US Sustainability Core 1 ETF 0.00003684 43.47
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000104799 16.69
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00044 165.56
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 6.235
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00356256 42.85
AVSC Avantis U.S. Small Cap Equity ETF 0 63.9
VTS.AX Vanguard US Total Market Shares Index ETF 0.00005 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00044 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00005 311.9
RSSL Global X Funds 0 101.845
DXUV Dimensional ETF Trust 0.00002398 62.375
RFLR Innovator ETFs Trust 0 29.365
Unlock